氧化低密度脂蛋白自身抗體Elisa試劑盒-oLAB (Anti-Oxidized LDL Autoantibodies) ELISA Kit代理/參數(shù)/廠家-ELISA試劑盒-艾美捷科技有限公司

PRODUCT CENTER

ELISA試劑盒

產(chǎn)品中心

當(dāng)前位置：首頁 > 產(chǎn)品中心 > 免疫學(xué)產(chǎn)品 > ELISA試劑盒

購買方式: 90%產(chǎn)品中國有現(xiàn)貨庫存。銀行轉(zhuǎn)賬、電匯、支票、現(xiàn)金，在線支付寶及網(wǎng)銀支付，或直接與我們電話聯(lián)系400-6800-868

背景資料: Oxidized low density lipoprotein (oxLDL) is believed to play a critical role in the development and progression of atherosclerosis. Accumulation of oxLDL in macrophages and smooth muscle cells causes foam cell formation, an initial step in the disease. Autoantibodies against oxidatively modified LDL can be used as a parameter that consistently mirrors the occurrence of oxidation processes taking place in vivo. In fact, elevated levels of autoantibodies against oxLDL have been detected in the blood stream of patients with coronary artery disease. Moreover, recent studies indicate a correlation between autoantibodies against oxLDL and the progression of carotid atherosclerosis. Increased serum concentrations of oLAB have also been described in various diseases such as pre-eclampsia and systemic lupus erythematosus. Decreased oLAB titers were observed during septicemia and myocardial infarction.

產(chǎn)品描述: Method Indirect ELISA, HRP/TMB, 12×8-well detachable strips Sample type Serum Sample volume 50 μl / well Assay time 1.5 h / 30 min / 15 min Sensitivity 48 mU/ml Standard range 0 – 1,200 mU/ml Specificity Anti-oxidized LDL autoantibodies Precision In-between-run (n=5): ≤ 8 % CV Within-run (n=8): ≤ 4 % CV

其他: Biomedica Immunoassay(bmgrp)公司成立于1988年, 總部位于奧地利維也納，主要致力于研究、開發(fā)和生產(chǎn)基于ELISA方法用于臨床前研究相關(guān)標(biāo)記物檢測的工具。迄今為止Biomedica Immunoassay公司在心血管檢測及骨代謝檢測領(lǐng)域開發(fā)了一系列特色ELISA檢測試劑盒，Biomedica Immunoassay的生產(chǎn)過程符合GMP/GLP指南，并符合ISO 9001:2015管理體系，有CE認(rèn)證。Biomedica Immunoassay的產(chǎn)品根據(jù)FDA， EMEA和ICH指南進(jìn)行驗證，并具有驗證報告。